<section><h2><h1 style="text-align:center;">Test your oncology pharmacy knowledge!</h1><p> </p><p style="text-align:center;"><span style="font-size:16px;"></span></p></h2><p><p style="text-align:center;"><span style="font-size:16px;">This quiz has 5 questions in different areas of oncology. You will see how many you answered correctly and get answer explanations at the end.</span></p><p style="text-align:center;"><span style="font-size:16px;"> </span></p><p style="text-align:center;"><span style="font-size:16px;">Good luck!</span></p><p style="text-align:center;"><span style="font-size:16px;"> </span></p></p></section><section><h2><table role="presentation"><colgroup><col /></colgroup><tbody><tr><td><span style="font-size:16px;">JK is a 9 yo M that presents to the pediatrician with complaints of fatigue, easy bruising, and sore legs. A CBC reveals Hgb of 7.4 g/dL, platelets of 68,000 cells/mm3, and WBC of 52,000 cells/mm3 (with 16% peripheral blasts). Pathology results show acute lymphoblastic leukemia. What is the appropriate INDUCTION regimen for JK based on risk stratification?</span></td></tr></tbody></table><p> </p></h2></section><section><h3><table role="presentation"><colgroup><col /></colgroup><tbody><tr><td><span style="font-size:16px;">LJ is a 65 yo M with newly-diagnosed stage III multiple myeloma. He is not a transplant candidate. Laboratory tests show a SCr of 2.5 mg/dL, Hgb of 8 g/dL, and platelets of 100K/mm3. Which of the following regimens is preferred as induction therapy for this patient?</span></td></tr></tbody></table><p> </p></h3></section><section><h3><table role="presentation"><colgroup><col /></colgroup><tbody><tr><td><span style="font-size:16px;">AF is a 70 yo M with a 35-pack year smoking history who has recently been diagnosed with unresectable, stage III adenocarcinoma of the lung and has no actionable mutations. He received weekly paclitaxel/carboplatin concurrent with XRT; however, his treatment had to be stopped due to grade 2 pneumonitis but he was able to restart and complete therapy. What would be the next most appropriate therapy?</span></td></tr></tbody></table><h2><br /></h2></h3></section><section><h3><table role="presentation"><colgroup><col /></colgroup><tbody><tr><td><p><span style="font-size:16px;">MJ is a 63 yo right-handed F with a newly diagnosed CNS malignancy. MRI showed a periventricular right frontal abnormality with some involvement of the corpus callosum with a 1.2 cm focus of enhancement in the right middle frontal gyrus. She was evaluated by a neuro-surgeon and underwent a right frontal craniotomy with gross total resection of the right middle frontal lobe gyrus lesion. She has NKDA. Medications include: APAP 500 mg PRN. Lab data show CBC and CMP WNL. Her KPS is 100. Physical exam is unremarkable. The pathology report shows glioblastoma multiforme (GBM) that is IDH mutant. </span></p><p><span style="font-size:16px;"> </span></p><p><span style="font-size:16px;">Temozolomide and concurrent radiation were completed followed by 6 cycles of adjuvant temozolomide before clinical and radiographic progression. She was started on lomustine. After 3 cycles of lomustine therapy, MJ's disease progressed again. The doctor would like to start her on bevacizumab therapy. Which of the following is true of treatment with bevacizumab?</span></p></td></tr></tbody></table><p> </p></h3></section><section><h3><table role="presentation"><colgroup><col /></colgroup><tbody><tr><td><p><span style="font-size:16px;">A 46 yo F with new breast cancer will be starting adjuvant dose-dense AC (doxorubicin-cyclophosphamide). PMH: cesarean section x2, G2P2 with hyperemesis gravidarum in both pregnancies; non-smoker, no alcohol use. Her labs are all WNL. Her home medications include: multivitamin 1 tablet daily, oxycodone 5 mg/APAP 325mg 1 tablet every 4 hours as needed for pain after surgery. </span></p><p><span style="font-size:16px;"> </span></p><p><span style="font-size:16px;">Which antiemetic regimen would you recommend to prevent acute CINV prior to cycle 1 of chemotherapy, based on ASCO guidelines?</span></p></td></tr></tbody></table><h2><br /></h2></h3></section><section><h2><h2> </h2><h2>Oncology is hard!</h2></h2><p><p> </p><p>You might be a little disappointed by your quiz score. But don’t worry – learning oncology is challenging but it absolutely can be achieved by any pharmacist with enough time and support. </p><p> </p><p>Check out the answer explanations below and this link for helpful oncology resources 👇.</p><p> </p></p></section><section><h3><p> </p><p> </p><h2>You have some skills!</h2></h3><p><p> </p><p>Nice work! Sure, you might have missed 1 question – but these are hard questions that cover a lot of different disease areas. Keep up the learning!</p><p> </p><p>Check out the answer explanations below and this link for helpful oncology resources 👇.<br /></p><p> </p></p></section><section><h3><p> </p><p> </p><h2>You rocked that!</h2></h3><p><p> </p><p>You are on 🔥! Impressive, because these are hard questions that cover a lot of different disease areas.</p><p> </p><p>Check out the answer explanations below and this link for helpful oncology resources to continue to expand your knowledge 👇.<br /></p><p> </p></p></section>
